Back

Should we revascularise patients with stable HFrEF who do not have angina? - discussion

25 August 2023 (14:40 - 15:15)
Organised by: Logo
Congress Presentation Part of: Great Debate: should we revascularise patients with stable HFrEF who do not have angina? Treatment ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

2 More presentations in this session

Presentation thumbnail
We should revascularise patients with stable HFrEF who do not have angina: pro
Professor H. Thiele (Leipzig, DE)
Slides Video
Presentation thumbnail
We should revascularise patients with stable HFrEF who do not have angina: con
Professor J. Cleland (Glasgow, GB)
Slides Video

Access the full session

Session thumbnail
Great Debate: should we revascularise patients with stable HFrEF who do not have angina?
Video

The Event

Event poster

ESC Congress 2023

25 August 2023 14:40 CET
You may be interested in
thumbnail
Congress Presentation
First-line atrial fibrillation ablation should be offered to all patients with atrial fibrillation and heart failure with reduced ejection fraction (HFrEF) - discussion
thumbnail
Congress Presentation
We should revascularise patients with stable HFrEF who do not have angina: pro
thumbnail
Congress Presentation
We should revascularise patients with stable HFrEF who do not have angina: con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources